Next Article in Journal
Applications of the Whole-Cell System in the Efficient Biosynthesis of Heme
Next Article in Special Issue
Toxic Effects of Two Redox States of Thallium on Immortalised Hypothalamic GT1-7 Neuronal Cells
Previous Article in Journal
An Unsupervised Classification Algorithm for Heterogeneous Cryo-EM Projection Images Based on Autoencoders
Previous Article in Special Issue
Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Evaluation of the Cytotoxic Effects of Metal Oxide and Metalloid Oxide Nanoparticles: An Experimental Study

by
Marina P. Sutunkova
,
Svetlana V. Klinova
*,
Yuliya V. Ryabova
,
Anastasiya V. Tazhigulova
,
Ilzira A. Minigalieva
,
Lada V. Shabardina
,
Svetlana N. Solovyeva
,
Tatiana V. Bushueva
and
Larisa I. Privalova
Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, 30 Popov Street, 620014 Yekaterinburg, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(9), 8383; https://doi.org/10.3390/ijms24098383
Submission received: 30 March 2023 / Revised: 28 April 2023 / Accepted: 3 May 2023 / Published: 6 May 2023
(This article belongs to the Special Issue Toxicology, Nanotoxicology and Occupational Diseases 2.0)

Abstract

:
Industrial production generates aerosols of complex composition, including an ultrafine fraction. This is typical for mining and metallurgical industries, welding processes, and the production and recycling of electronics, batteries, etc. Since nano-sized particles are the most dangerous component of inhaled air, in this study we aimed to establish the impact of the chemical nature and dose of nanoparticles on their cytotoxicity. Suspensions of CuO, PbO, CdO, Fe2O3, NiO, SiO2, Mn3O4, and SeO nanoparticles were obtained by laser ablation. The experiments were conducted on outbred female albino rats. We carried out four series of a single intratracheal instillation of nanoparticles of different chemical natures at doses ranging from 0.2 to 0.5 mg per animal. Bronchoalveolar lavage was taken 24 h after the injection to assess its cytological and biochemical parameters. At a dose of 0.5 mg per animal, cytotoxicity in the series of nanoparticles changed as follows (in decreasing order): CuO NPs > PbO NPs > CdO NPs > NiO NPs > SiO2 NPs > Fe2O3 NPs. At a lower dose of 0.25 mg per animal, we observed a different pattern of cytotoxicity of the element oxides under study: NiO NPs > Mn3O4 NPs > CuO NPs > SeO NPs. We established that the cytotoxicity increased non-linearly with the increase in the dose of nanoparticles of the same chemical element (from 0 to 0.5 mg per animal). An increase in the levels of intracellular enzymes (amylase, AST, ALT, LDH) in the supernatant of the bronchoalveolar lavage fluid indicated a cytotoxic effect of nanoparticles. Thus, alterations in the cytological parameters of the bronchoalveolar lavage and the biochemical characteristics of the supernatant can be used to predict the danger of new nanomaterials based on their comparative assessment with the available tested samples of nanoparticles.

Graphical Abstract

1. Introduction

Particles in the nanometer range are considered to be an airborne hazard, mainly because of their size, which determines their interaction with the structures of an organism [1]. Larger particles tend to deposit in the upper airways, smaller ones deposit in the trachea and bronchi, while fine particles (<2 μm) can be delivered to the alveoli and are more prone to systemic action [2]. Metal nanoparticles (NPs), for instance, exhibit the highest systemic toxicity and to a greater extent cause local reactions in the organism following inhalation exposure [3], some of which are determined by the specific characteristics of the chemical element that form the nanoparticles and activate certain mechanisms of toxicity. It is also believed that the cytotoxicity of nanoparticles increases with the atomic number of their basic chemical element [4].
Numerous studies both in vitro and in vivo have demonstrated the cytotoxic effects of nanoparticles on lung tissue. A stimulation of reactive oxygen species production and a decrease in the level of adenosine triphosphate was observed in the culture of the A549 cancer cell line obtained from a human bronchoalveolar carcinoma following exposure to aluminum, titanium, and silicon dioxide nanoparticles sized 10 to 60 nm [5]. The exposure to silicon dioxide nanoparticles with diameters of 15 and 46 nm induced a dose-dependent decrease in cell viability and a simultaneous increase in the concentration of reactive oxygen species (ROS) in the medium [6]. Zinc oxide nanoparticles had a toxic effect on human pulmonary alveolar epithelial cells (HPAEpiC), inducing ROS formation and accumulation in mitochondria by inhibiting the activity of superoxide dismutase (SOD) and reducing the level of glutathione (GSH). ROS, in turn, open the mitochondrial Ca2+ pathway and reduce mitochondrial membrane potentials, leading to apoptosis [7]. Yu et al. [8] also reported the influence of zinc oxide NPs on the membrane potential of mitochondria. A comparative analysis of the effects of Fe2O3 and ZnO NPs on BEAS-2B and A549 cell lines showed that ZnO NPs, but not Fe2O3 NPs, cause cell cycle arrest, cell apoptosis, ROS production, mitochondrial dysfunction, and impaired glucose metabolism, which are responsible for cytotoxicity [9]. Fe3O4 NPs, however, can also lead to disturbances in mitochondrial activity, boost ROS production in cells, and lead to a significant decrease in the ATP level [10].
Experiments in vivo have shown a toxic effect of indium tin oxide nanoparticles in rats inducing acute inflammation after intratracheal instillation [11]. A short-term inhalation exposure to cerium oxide nanoparticles caused pulmonary inflammation in rats [12]. An intratracheal instillation of CuO NPs in C57BL/6 mice caused lung fibrosis by inducing apoptosis of epithelial cells, partially attributed to an increased number of ROS, and exacerbating inflammation in the lung tissue in a dose-dependent manner [13]. An experiment on rats showed that a 10-month chronic inhalation exposure to NiO NPs induced manifestations of systemic toxicity against unexpressed lung pathology related to a rather low chronic retention of nanoparticles in lungs [14]. Dumkova et al. [15] demonstrated a similar systemic toxicity following inhalation exposure to lead oxide nanoparticles.
Intratracheal instillations are just as useful for ranking the toxicity of nanoparticles as inhalation exposure studies [16]. It is, therefore, of interest to study the cytotoxicity of nanoparticles of different chemical natures instilled intratracheally at various doses.

2. Results

2.1. Comparative Analysis of Nanoparticles of Various Chemical Natures

2.1.1. Cytological Characteristics of Bronchoalveolar Lavage Fluid (BALF) Following Exposure to Nanoparticles

In the series of nanoparticles of various element oxides (CuO, PbO, CdO, Fe2O3, NiO, and SiO2) tested at a dose of 0.5 mg per animal, we established that CuO and CdO NPs caused the greatest influx of cells into the lungs, at a rate that was 8.4 and 6.0 times higher compared to the controls, respectively (p < 0.05) (Figure 1a). The smallest 1.3 and 1.8-fold influxes were observed following exposure to Fe2O3 and SiO2 NPs, respectively.
The exposure to CuO NPs was found to induce the highest increase in the number of neutrophilic leukocytes (by 34.9 times compared to the controls, p < 0.05) followed by the exposure to CdO NPs, leading to a 22.3-fold increase. Instilled Fe2O3 and SiO2 nanoparticles, in their turn, did not affect this indicator.
A statistical increase in the number of alveolar macrophages was established following the exposure to NiO nanoparticles (by 1.85 times, p < 0.05). We found an increase in the number of alveolar macrophages to approximately the same degree after the exposure to CdO and CuO nanoparticles (by 1.64 and 1.86 times, respectively).
The main indicator of a cytotoxic effect is the ratio of neutrophilic leukocytes to alveolar macrophages. Its value demonstrated the highest (17.7-fold) increase under the effect of CuO NPs and a slightly lower one (by 14.3 times) following the exposure to CdO NPs (p < 0.05). The smallest changes in the ratio were observed in the rats exposed to Fe2O3 (by 1.8 times compared to the controls, p < 0.05) and SiO2 nanoparticles.
In the series of nanoparticles of element oxides (NiO, Mn3O4, SeO, and CuO) tested at a dose of 0.25 mg per animal (Figure 2), the largest influx of cells to the lungs was found in the NiO NP exposure group, which appeared to be 7.7 times higher than in the controls (p < 0.05), owing to a 77.5-fold increase in the number of neutrophilic leukocytes and a 3.6-fold increase in that of alveolar macrophages (p < 0.05).
The Mn3O4 NPs increased the influx of neutrophilic leukocytes by 26.3 times compared to the controls (p < 0.05). The dose of 0.25 mg CuO NPs per animal induced a significant influx of neutrophilic leukocytes (by 3.0 times compared to the controls, p < 0.05).
The NiO, Mn3O4, and CuO nanoparticles demonstrated a pronounced cytotoxic effect, as shown by the NL/AM ratios, which were 20, 11.2, and 2.1 times higher than that in the controls (p < 0.05). It is worth noting that the SeO NPs caused a slight increase in the total BALF cell count (by 1.5 times compared to the controls, p < 0.05), while other BALF cytological parameters only tended to increase.

2.1.2. Biochemical Parameters of BALF Following Nanoparticle Exposure

Altered biochemical indices of the supernatant of the bronchoalveolar lavage were found after the exposure to NPs at a dose of 0.5 mg per animal (Figure 3). The highest increases in the level of enzymes under study (amylase, ALT, AST, GGT, and LDH) were noted following the exposures to CdO and CuO NPs. Mild reactions were observed following the instillations of PbO, NiO, and SiO2 NPs. Fe2O3 NPs, on the opposite, led to a decrease in the levels of enzymes in the BALF supernatant.
The exposure to element oxide nanoparticles at a dose of 0.25 mg per animal (Figure 4) caused changes in enzyme activity to one degree or another compared with the controls.
A significant increase in enzyme activity in the supernatant was observed by the level of amylase and LDH after exposure to Mn3O4 NPs. The LGH level was also found to be higher in the CuO NP exposure group.

2.2. Comparative Analysis of Nanoparticles at Different Exposure Doses

2.2.1. Characteristics of BALF after Intratracheal Instillation of Copper Oxide Nanoparticles

The cytological characteristics of BALF after the instillation of CuO NPs at different doses did not change monotonic with the increasing dose (Figure 5).
The greatest response was observed to a dose of 0.5 mg per animal. At the same time, a lower dose of 0.2 mg per animal caused greater changes in the influx of neutrophilic leukocytes than that of 0.25 mg per animal. This led to a statistical increase in the NL/AM ratio after the administration of CuO NPs at a dose of 0.2 mg per animal, while that of 0.25 mg per animal only indicated a rising trend.
The values of the biochemical parameters of the supernatant after the instillation of CuO NPs rose monotonically with the NP dose (Figure 6). The most indicative in this regard were such enzymes as ALT, AST, and LDH.

2.2.2. Characteristics of BALF after Intratracheal Instillation of Lead Oxide Nanoparticles

The indicator of the total BALF cellularity demonstrated a monotonic dose-dependent increase (Figure 7a). At the same time, the influx of neutrophilic leukocytes and alveolar macrophages was higher at a lower dose of NPs. Hence, the main cytotoxicity index (NL/AM ratio) was also higher in response to a lower dose of PbO NPs.
The pattern of alterations in the biochemical parameters of the supernatant with an increase in the dose of PbO NPs was ambiguous (Figure 8). Only the GGT level increased statistically in response to the dose of 0.2 mg per animal. The remaining indices showed a tendency either to a monotonic increase (like amylase) or to a monotonic decrease (ALT), changed non-monotonically (AST), or remained at the level of control values (LDH).

2.2.3. Characteristics of BALF after Intratracheal Instillation of Nickel Oxide Nanoparticles

We observed a statistical increase in all the studied cytological characteristics of BALF after the exposure to NiO NPs at a dose of 0.25 mg/rat (Figure 9). A higher dose of 0.5 mg/rat induced an increase in the total BALF cellularity (p < 0.05), as well as a statistically significant increase in the number of neutrophils (p < 0.05). It is clearly seen that the cytological changes were more pronounced following the lower-dose exposure.
The studied biochemical parameters tended to increase following the exposure to NiO NPs at different doses (Figure 10).

3. Discussion

3.1. Relationship between the Chemical Composition of Nanoparticles and Their Cytotoxicity

When foreign particles, including nanoparticles, enter the lower airways, the phagocytic activity is mobilized, which is expressed by an increase in the number of neutrophilic leukocytes (NL) and alveolar macrophages (AM) in the bronchoalveolar lavage fluid (BALF). Alveolar macrophages are the first to phagocytize foreign particles. The products of their destruction stimulate the influx of neutrophilic leukocytes, and the more cytotoxic these particles are, that is, the more damage they cause in the lung tissue or the population of phagocytic cells, the greater the influx of neutrophilic leukocytes [17,18]. The cellular shift towards neutrophilic leukocytes, which is estimated by the NL/AM ratio, is therefore a key indicator of the cytotoxic effect [19,20,21].
When assessing the impact of the chemical nature of nanoparticles at a dose of 0.5 mg per animal, the largest neutrophilic leukocyte influx was observed in the CuO NP exposure group (Figure 2a). It is important to note that, among the elements studied in the form of oxide nanoparticles, copper is an essential element, while the CuO NPs had an even greater cytotoxic effect than the particles of such non-essential elements as lead and cadmium. This might be attributed to the fact that CuO NPs are highly redox active nanoparticles leading to high ROS formation due to their large active surface area, rapid dissolution, and an easy change in the oxidation state of dissolved copper [22]. Other authors also reported higher cytotoxicity and DNA damage due to CuO NPs compared to TiO2, ZnO, CuZnFe2O4, Fe3O4, and Fe2O3 nanoparticles, carbon and nanotubes [23]. In a recent review [24] on the effect of copper nanoparticles on the lungs of mice and rats following intranasal exposure, the authors mentioned the development of inflammation, ROS generation, alveolitis, bronchiolitis, fibrosis, and destruction of the epithelium. The intratracheal instillation of CuO NPs induced acute bronchioloalveolar inflammation with diffuse pulmonary edema, indicating the pulmonary toxicity of CuO NPs [25]. An excess of free copper ions leads to a cascade of redox reactions leading to formation of reactive oxygen species, which destroy the cell both inside and outside. We must note that the ROS generation additionally induced by membrane lipid peroxidation under effect of NPs can lead to a loss of membrane elasticity, which, like an abnormally high fluidity, inevitably leads to cell death [1]. In addition, with regard to such essential elements as copper, it is impossible to exclude the contribution of mechanisms intended for their entry into the cell from the implementation of the toxic effect. In their experiments on HepG2 hepatocytes, Cuillel et al. [26] showed that NPs penetrate inside (most likely by endocytosis), bypassing the cellular defense mechanisms against excess copper.
The PbO NPs had a cytotoxic effect, as shown by the increase in total cellularity and the NL/AM ratio (Figure 2a,d), but to a much lesser extent than CuO or CdO NPs, which is most likely related to the lower cytotoxicity of this element. It is known that semi-lethal doses of lead and its compounds are higher than those of cadmium [27].
The NiO NPs at a dose of 0.5 mg per animal caused the largest influx of alveolar macrophages compared to the other NPs (Figure 2c). At the same time, at a lower dose, the NiO NPs caused a steady increase in all the cytological parameters of BALF (Figure 3). A neutrophilic and lymphocytic inflammatory response appeared 24 h after intratracheal instillation of NiO NPs in a study by Jeong et al. [28]. Other researchers have demonstrated that nickel NPs induce oxidative stress, severe and persistent inflammation in the lungs, and fibrosis [29,30].
The instillation of Mn3O4 NPs increased the influx of neutrophilic leukocytes and the NL/AM ratio revealing the cytotoxicity of those NPs. Manganese is essential for living organisms as a cofactor for enzymes, yet, high levels of environmental (polluted water) and occupational (welding) exposure to this metal can lead to neurological disorders, including manganism, a condition similar to Parkinson’s disease. A recent review has presented data on the toxic properties of manganese and its authors conclude that Mn NPs can be both toxic and non-toxic. The latter is observed with various modifications of NPs [31], e.g., BSA-modified Mn3O4 NPs exhibit excellent antioxidant activity [32].
A number of studies have shown that iron NPs have a low pulmonary toxicity both in vitro and in vivo [33,34,35]. In our experiment, the Fe2O3 NPs caused a minimal influx of neutrophilic leukocytes and a decrease in the number of alveolar macrophages, leading to a significant increase in their ratio. It is noteworthy that in this case too, the NL/AM ratio indicates the cytotoxic effect of Fe2O3 NPs, although it does not cause an active macrophage influx into the lungs. The latter may indirectly indicate a lesser destruction of cells that have absorbed Fe2O3 NPs compared to the effect of other metal oxide NPs.
The SiO2 and SeO NPs demonstrated no pronounced cytotoxic properties in our study. For SiO2 NPs, this was probably due to the inertness and low solubility of this oxide in biological fluids. Fukui et al. [36] showed that the contribution of oxidative stress to the pulmonary toxicity of crystalline SiO2 was minimal at the early acute stage after exposure. Toxic effects have been observed following intratracheal administration of synthetic amorphous silica nanomaterials, but the genotoxic effects of SiO2 NPs were null [37]. Only a significantly higher dose of SiO NPs (50 mg/kg) with a longer exposure (7 to 56 days) has led to the development of granulomatous inflammation in the lungs of rats, followed by progressive and massive fibrous nodules [38].
In the case of SeO NPs, we can speak about the manifestation of the dual nature of selenium: the cytotoxic effect of its nanoparticles on the one hand and the protective effect of selenium as a trace element on the other. The NPs are insoluble in water and highly soluble in biological fluids [39], thus suggesting the incomplete dissolution of SeO NPs in the upper airways. Those undissolved particles could contribute to an increase in the influx of cells due to some mobilization of neutrophilic leukocytes and alveolar macrophages, as evidenced by their slightly increased ratio. It was these particles deposited in the respiratory tract that phagocytized alveolar macrophages: Chen et al. [40] argue that selenium nanoparticles themselves are the “driving force” of toxicity, while dissolved ions make only a minor contribution. At the same time, alveolar macrophages were not yet damaged by the absorbed particles and were not destroyed, which can be judged by the biochemical parameters of the BALF supernatant, in which the content of the intracellular enzymes did not differ statistically from the corresponding control values. We suggest that selenium, as an antioxidant, is involved in the inhibition of oxidative stress induced by insoluble NPs at its various levels.
The biochemical testing of the supernatant deepened the analysis of our experimental data.
In our studies, GGT showed no pronounced sensitivity to the instillation of nanoparticles. Despite the apparent cell destruction, the natural variability of this enzyme is likely to be high, which led to a large scatter of the data and the absence of significant differences. Interestingly, GGT is a membrane-bound enzyme involved in the transfer of the glutamyl moiety of glutathione to other amino acids and dipeptides [41].
The intracellular glycolytic enzyme LDH is used to analyze the integrity of the cell membrane [25,42,43]. It is an important marker of cellular destruction. A high degree of cell membrane destruction occurred after exposure to the CuO NPs (at doses of 0.25 and 0.5 mg per animal), CdO NPs (at a dose of 0.5 mg per animal), and Mn3O4 NPs (at a dose of 0.25 mg per animal), as can be seen from Figure 3e and Figure 4c. The nanoparticles of other element oxides did not lead to significant increases in LDH.
Increases in amylase were observed after the instillation of the same CuO, CdO, and Mn3O4 NPs, probably associated with a large influx of cells into the lungs and their destruction. Cell death causes a release of fibrogenic factors, which lead to the activation of the growth of connective tissue. An increase in the level of amylase in BALF has been shown in inflammatory and carcinogenic lesions of the lungs [44,45,46], as well as in the exacerbation of chronic obstructive pulmonary disease [47] and aspiration pneumonia [48,49]. All the above processes are accompanied by inflammation and cell proliferation, be it tumor cells or fibroblasts. We assume that it is the active growth of the connective tissue that accounts for a rise in amylase in the supernatant and can serve as a characteristic not of cytotoxicity, but of fibrogenicity of the particles in question.
Exposure to the same CuO, CdO, and Mn3O4 NPs led to an increase in AST and ALT levels in the supernatant. These two enzymes are also intracellular (mainly located in the cytosol) [50], thus indicating damage to lung cells as well. Therefore, an increase in intracellular enzymes in the supernatant indicates an explicit cytotoxic effect of NPs.

3.2. Relationship between the Dose of Nanoparticles and Their Cytotoxic Effects

It is known that the vast majority (85.7%) of dose–response relationships observed after exposure to various pollutants are nonlinear [51]. Such polyphase links have been repeatedly shown in in vitro experiments [52,53]. Thus, according to the main cytological indicator, i.e., the ratio of neutrophilic leukocytes to alveolar macrophages, the highest response following exposure to PbO NPs (Figure 8d) occurred at a dose of 0.2 mg per rat, which was not the highest among those tested by us. At the same time, a similar trend can be traced for some biochemical parameters of the supernatant (AST, GGT) (Figure 9c,d). The contribution of dimensionality cannot be ruled out either, e.g., particles 47 ± 16 nm in size at a dose of 0.2 mg per animal (in contrast to smaller particles 23 ± 5 nm in size at a dose of 0.5 mg per animal) could be easily recognized by defense systems of the body [1] and phagocytosed without causing damage to lung cells, alveolar macrophages, or neutrophilic leukocytes.
In the studies of exposure to NiO NPs at different doses, similar to the PbO NPs, changes in the cytological parameters in response to increasing doses were non-monotonic (Figure 9). In contrast to the PbO NPs, the NiO NPs were all of the same size. The main indicator of nanoparticle cytotoxicity was statistically increased after the NiO NP exposure at the dose of 0.25 mg/rat due to an active influx of neutrophils while it only tended to increase under the effect of a higher exposure level. It can be assumed that the NP dose contributes more to the toxic effect of nanoparticles than their size but this assumption still needs to be tested. At the same time, the levels of enzymes, including intracellular ones (Figure 10), in the supernatant were somewhat increased, which may indirectly indicate the destruction of some cells under the influence of trapped NPs.
The exposure to CuO NPs induced the highest response at the dose of 0.5 mg per rat, followed by that of 0.2 mg but not of 0.25 mg per rat (Figure 6). At the same time, judging by the evaluation of the biochemical parameters of the bronchoalveolar lavage fluid (Figure 7), we can assume a linear dose–effect relationship.
An increase in the influx of cells owing to alveolar macrophages and, mainly, neutrophilic leukocytes (Figure 6), which does not correlate with changes in BALF biochemical parameters (Figure 7), can be attributed to a dual nature of copper acting as a toxicant and a trace metal. We assume that if the cytoprotective properties of copper can still be observed at a dose of 0.2 mg per rat, then at a dose of 0.25 mg per rat its cytotoxic effects already predominate.
Further studies are needed to clarify the nature and dependency type of the dose–response relationships between size, concentration, and identity of NPs.

4. Materials and Methods

4.1. Synthesis of Nanoparticles

The suspensions of nanoparticles were obtained by laser ablation of 99.99% pure, 1 mm thick plates of elements in ca. 30 mL of deionized water. The Fmark-20RL laser system (LTC, Saint Petersburg, Russia) based on a Yb fiber laser with a wavelength of 1080 nm, pulse duration of 100 ns, pulse energy of 1 mJ, and repetition rate of 21 kHz was used. The target surface, cleaned by deionized water in an ultrasonic bath, was processed with a spot of laser irradiation with a fixed diameter of 40 μm and the fluence ranged from 15 to 80 J/cm2. The water layer thickness above the target ranged from 2 to 10 mm. The scanning velocity was about 270 mm/s, while the scanned area ranged from 25 to 300 mm2. A motor-driven agitator was used to reduce the scattering of the laser beam on cavitation bubbles and to remove the ablated nanoparticle cloud from the irradiated area during ablation. The ablation process lasted from 1 to 60 min. The value of the ablated mass was measured by weighing the target before and after ablation using a ME 235 S analytical balance (Sartorius AG, Göttingen, Germany).
This technique produced suspensions with a sufficiently narrow size distribution of nanoparticles (NPs) and although the singlet NPs tend to stick together, the resulting aggregates were usually loose and rather small (Figure 11).
All the element oxide NPs under study had a spherical shape. Their sizes and experimental doses are shown in Table 1.
The suspension stability was characterized by the value of Zeta potential measured by electrophoretic light scattering using a Zetasizer Nano ZS analyzer (Malvern Panalytical, Malvern, UK). A high suspension stability (Zeta potential up to 42 mV) allowed us to increase the concentration of NPs by partial water evaporation at 50 °C on a heat plate. The concentrations of the stable suspension were achieved without appreciable change in the size and chemical composition of the synthesized nanoparticles. The size distribution was measured by dynamic light scattering (DLS) using the Zetasizer Nano ZS analyzer and by a statistical analysis of the high-resolution images obtained using a CrossBeam Workstation Auriga scanning electron microscope (SEM) (Carl Zeiss, Jena, Germany). The results showed that the suspensions produced as above were highly stable and maintained their characteristics without increasing particle aggregation over periods sufficient for carrying out the animal experiments described below. No chemical stabilizers were added to either of the suspensions.

4.2. Experimental Animals

The experiment was conducted on outbred female albino rats aged 3.5 months and weighing about 200 g at the start. The animals were kept in a separate vivarium room of our center. They breathed unfiltered air and were given bottled artesian water and standard balanced feed. The rats were randomly assigned into 17 groups of 10 animals. We conducted 5 experiments: (1) CuO, PbO, CdO, Fe2O3, and NiO nanoparticles at a dose of 0.5 mg per animal; (2) SiO2 nanoparticles at a dose of 0.5 mg per animal; (3) NiO and Mn3O4 nanoparticles at a dose of 0.25 mg per animal; (4) CuO and SeO nanoparticles at a dose of 0.25 mg per animal; (5) CuO and PbO nanoparticles at a dose of 0.2 mg per animal. Each experiment had its own control group.
Treated animals were intratracheally administered with various doses of nanoparticles (1 mL). The control group received 1 mL deionized water.
The experiment was designed and implemented in accordance with the International Guiding Principles for Biomedical Research Involving Animals developed by the Council for International Organizations of Medical Sciences and the International Council for Laboratory Animal Science (2012), and was approved by the Ethics Committee of the Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers (Protocol No. 53 of 21 January 2014; Protocol No. 58 of 18 January 2016; Protocol No. 9 of 8 October 2018; Protocol No. 2 of 20 April 2020; and Protocol No. 2 of 20 April 2021).

4.3. Cytotoxicity Assessment

The cytotoxicity of nanoparticles was assessed by alveolar phagocytosis. Animals were injected intratracheally with 1 mL of a suspension of nanoparticles under ether round anesthesia. After 24 h, the bronchoalveolar lavage fluid was collected and a sample of the fluid with cells was obtained using a laboratory mixer. The cells were stained with methylene blue in 3% (v/v) acetic acid solution. We then counted the total number of cells in the aliquot using a light microscope in the Goryaev chamber with the following recalculation for the total volume of bronchoalveolar lavage fluid (BALF).
Then, 200 g of the BALF was centrifuged at 1000 r/min for 4 min and the supernatant was taken for biochemical testing of amylase, aspartate and alanine aminotransferase (AST, ALT), lactate dehydrogenase (LDH), and gamma-glutamyl transpeptidase (GGT) using a Cobas Integra 400 plus automated analyzer (Roche Diagnostics GmbH, Germany) with the appropriate test kits: alfa-Amylase EPS COBAS INTEGRA/cobas c system, AST IFCC COBAS INTEGRA/cobas c system, ALT IFCC COBAS INTEGRA/cobas c system, Lactate Dehydrogenase acc. to IFCC COBAS INTEGRA/cobas c system, and GGT IFCC COBAS INTEGRA/cobas c system (Roche Diagnostics GmbH, Switzerland). All the clinical laboratory BALF tests were performed using the techniques described in the many manuals [54].
The cell pellets were carefully resuspended in a small amount of the supernatant to prepare liquid-based preparations that were air dried, fixed in methanol, and stained with azure eosin methylene blue. At least 100 cells were counted on each smear using a light microscope while identifying alveolar macrophages, neutrophilic leukocytes, and eosinophils.
A single intratracheal instillation of 1 mL of NP water suspension (or of the same de-ionized water without particles for the controls) served as an experimental model for the response of the lower airways to particle deposition. The adequacy of this model for solving such problems is sufficient as it has been shown repeatedly that important qualitative and quantitative patterns of the response of the pulmonary free cell population (in particular, its dependence on the cytotoxicity of deposited particles) observed in inhalation exposures to dust particles are principally the same in the case of their intratracheal administration [17]. Animal experiments based on comparative inhalation exposures to nanoparticles and microparticles with known characteristics in equal concentrations would be, above any doubt, desirable. However, such experiments are associated with technical and financial difficulties that considerably limit research opportunities.

4.4. Statistical and Mathematical Analysis

The statistical significance of differences between the group arithmetic means was estimated using Student’s t-test with Bonferroni correction for multiple comparisons.
We normalized the data in the experimental groups to the same values in the corresponding control groups to compare parameters in different experiments, taking the control values as 1.

5. Conclusions

The experiments with single instillations of CuO, PbO, CdO, Fe2O3, NiO, SiO2, Mn3O4, and SeO nanoparticles at different doses (0 to 0.5 mg per animal) have shown the following.
The chemical nature of nanoparticles determines their cytotoxicity, probably due to increased oxidative stress, penetration of NPs into cells and their dissolution in biological fluids. At a dose of 0.5 mg per animal, the level of cytotoxicity declines in the following order: CuO NPs > PbO NPs > CdO NPs > NiO NPs > SiO2 NPs > Fe2O3 NPs. At a dose of 0.25 mg per animal, the cytotoxicity changes as follows: NiO NPs > Mn3O4 NPs > CuO NPs > SeO NPs.
Cytotoxicity demonstrates a non-linear increase with an increasing dose of the same chemical element (from 0 to 0.5 mg per animal). Thus, NPs of essential copper are likely to exert both protective and toxic effects while lead and nickel nanoparticles cause damage in all studied dose ranges.
A high level of intracellular enzymes (amylase, AST, ALT, and LDH) in the supernatant gives evidence of the cytotoxic effect of nanoparticles.
Alterations in the cytological parameters of the bronchoalveolar lavage and biochemical characteristics of the supernatant can be used to predict the danger of new nanomaterials based on their comparative assessment with the available tested samples of nanoparticles.
Finally, we should note that further studies are needed to clarify the nature and dependency type of the dose–response relationships between size, concentration, and identity of NPs.

Study Limitations

The experiments were conducted at different times using animals of more than one livestock. Such physical characteristics of nanoparticles as solubility in water and biological fluids, charge, adsorption capacity, resistance to aggregation, hydrophobicity, adhesion to surfaces, and the ability to generate free radicals have not been studied. Extrapolation of data from rodents to humans shall be done with caution, since cytotoxicity has been characterized only based on the main cellular and biochemical parameters.

Author Contributions

Study conception and design—M.P.S. and I.A.M.; data collection and processing—S.V.K., Y.V.R., A.V.T., L.V.S., S.N.S. and T.V.B.; draft manuscript preparation—S.V.K. and Y.V.R.; figure preparation—L.V.S.; revision—M.P.S. and I.A.M.; supervision—L.I.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The animal study protocols were approved by the Institutional Ethics Committee of the Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers (Protocol No. 53 of 21 January 2014; Protocol No. 58 of 18 January 2016; Protocol No. 9 of 8 October 2018; Protocol No. 2 of 20 April 2020; and Protocol No. 2 of 20 April 2021).

Informed Consent Statement

Not applicable.

Acknowledgments

The authors would like to express their sincere gratitude to the personnel of the Ural Center for Collective Use “Modern Nanotechnologies” of the Ural Federal University named after the First President of Russia B.N. Yeltsin and personally to Vladimir Ya. Shur for the synthesis of nanoparticle suspensions with the specified characteristics.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sukhanova, A.; Bozrova, S.; Sokolov, P.; Berestovoy, M.; Karaulov, A.; Nabiev, I. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res. Lett. 2018, 13, 44. [Google Scholar] [CrossRef] [PubMed]
  2. Darquenne, C. Aerosol deposition in health and disease. J. Aerosol Med. Pulm. Drug. Deliv. 2012, 25, 140–147. [Google Scholar] [CrossRef] [PubMed]
  3. Prasad, R.Y.; McGee, J.K.; Killius, M.G.; Suarez, D.A.; Blackman, C.F.; DeMarini, D.M.; Simmons, S.O. Investigating oxidative stress and inflammatory responses elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: Effect of size, surface coating, and intracellular uptake. Toxicol. Vitr. 2013, 27, 2013–2021. [Google Scholar] [CrossRef] [PubMed]
  4. Huang, Y.W.; Cambre, M.; Lee, H.J. The toxicity of nanoparticles depends on multiple molecular and physicochemical mechanisms. Int. J. Mol. Sci. 2017, 18, 2702. [Google Scholar] [CrossRef]
  5. Wu, Y.; Wang, M.; Luo, S.; Gu, Y.; Nie, D.; Xu, Z.; Wu, Y.; Chen, M.; Ge, X. Comparative toxic effects of manufactured nanoparticles and atmospheric particulate matter in human lung epithelial cells. Int. J. Environ. Res. Public Health 2020, 18, 22. [Google Scholar] [CrossRef]
  6. Lin, W.; Huang, Y.W.; Zhou, X.D.; Ma, Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217, 252–259. [Google Scholar] [CrossRef]
  7. Xie, S.; Zhu, J.; Yang, D.; Xu, Y.; Zhu, J.; He, D. Low concentrations of zinc oxide nanoparticles cause severe cytotoxicity through increased intracellular reactive oxygen species. J. Biomed. Nanotechnol. 2021, 17, 2420–2432. [Google Scholar] [CrossRef]
  8. Yu, K.N.; Yoon, T.J.; Minai-Tehrani, A.; Kim, J.E.; Park, S.J.; Jeong, M.S.; Ha, S.W.; Lee, J.K.; Kim, J.S.; Cho, M.H. Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol. Vitr. 2013, 27, 1187–1195. [Google Scholar] [CrossRef]
  9. Lai, X.; Wei, Y.; Zhao, H.; Chen, S.; Bu, X.; Lu, F.; Qu, D.; Yao, L.; Zheng, J.; Zhang, J. The effect of Fe2O3 and ZnO nanoparticles on cytotoxicity and glucose metabolism in lung epithelial cells. J. Appl. Toxicol. 2015, 35, 651–664. [Google Scholar] [CrossRef]
  10. Zhang, X.; Zhang, H.; Liang, X.; Zhang, J.; Tao, W.; Zhu, X.; Chang, D.; Zeng, X.; Liu, G.; Mei, L. Iron oxide nanoparticles induce autophagosome accumulation through multiple mechanisms: Lysosome impairment, mitochondrial damage, and ER Stress. Mol. Pharm. 2016, 13, 2578–2587. [Google Scholar] [CrossRef]
  11. Liu, N.; Guan, Y.; Zhou, C.; Wang, Y.; Ma, Z.; Yao, S. Pulmonary and systemic toxicity in a rat model of pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles. Int. J. Nanomed. 2022, 17, 713–731. [Google Scholar] [CrossRef]
  12. Guo, C.; Robertson, S.; Weber, R.J.M.; Buckley, A.; Warren, J.; Hodgson, A.; Rappoport, J.Z.; Ignatyev, K.; Meldrum, K.; Römer, I.; et al. Pulmonary toxicity of inhaled nano-sized cerium oxide aerosols in Sprague–Dawley rats. Nanotoxicology 2019, 13, 733–750. [Google Scholar] [CrossRef] [PubMed]
  13. Lai, X.; Zhao, H.; Zhang, Y.; Guo, K.; Xu, Y.; Chen, S.; Zhang, J. Intranasal delivery of copper oxide nanoparticles induces pulmonary toxicity and fibrosis in C57BL/6 mice. Sci. Rep. 2018, 8, 4499. [Google Scholar] [CrossRef] [PubMed]
  14. Sutunkova, M.P.; Solovyeva, S.N.; Minigalieva, I.A.; Gurvich, V.B.; Valamina, I.E.; Makeyev, O.H.; Shur, V.Y.; Shishkina, E.V.; Zubarev, I.V.; Saatkhudinova, R.R.; et al. Toxic effects of low-level long-term inhalation exposures of rats to nickel oxide nanoparticles. Int. J. Mol. Sci. 2019, 20, 1778. [Google Scholar] [CrossRef] [PubMed]
  15. Dumková, J.; Smutná, T.; Vrlíková, L.; Le Coustumer, P.; Večeřa, Z.; Dočekal, B.; Mikuška, P.; Čapka, L.; Fictum, P.; Hampl, A.; et al. Sub-chronic inhalation of lead oxide nanoparticles revealed their broad distribution and tissue-specific subcellular localization in target organs. Part. Fibre Toxicol. 2017, 14, 55. [Google Scholar] [CrossRef]
  16. Morimoto, Y.; Izumi, H.; Yoshiura, Y.; Tomonaga, T.; Lee, B.W.; Okada, T.; Oyabu, T.; Myojo, T.; Kawai, K.; Yatera, K.; et al. Comparison of pulmonary inflammatory responses following intratracheal instillation and inhalation of nanoparticles. Nanotoxicology 2016, 10, 607–618. [Google Scholar] [CrossRef]
  17. Katsnelson, B.A.; Konysheva, L.K.; Privalova, L.I.; Morosova, K.I. Development of a multicompartmental model of the kinetics of quartz dust in the pulmonary region of the lung during chronic inhalation exposure of rats. Brit. J. Ind. Med. 1992, 49, 172–181. [Google Scholar] [CrossRef]
  18. Privalova, L.I.; Katsnelson, B.A.; Sharapova, N.Y.; Kislitsina, N.S. On the relationship between activation and breakdown of macrophages in the pathogenesis of silicosis (an overview). Med. Lav. 1995, 86, 511–521. [Google Scholar]
  19. Grommes, J.; Soehnlein, O. Contribution of neutrophils to acute lung injury. Mol. Med. 2011, 17, 293–307. [Google Scholar] [CrossRef]
  20. Privalova, L.I.; Katsnelson, B.A.; Osipenko, A.B.; Yushkov, B.N.; Babushkina, L.G. Response of a phagocyte cell system to products of macrophage breakdown as a probable mechanism of alveolar phagocytosis adaptation to deposition of particles of different cytotoxicity. Environ. Health Perspect. 1980, 35, 205–218. [Google Scholar] [CrossRef]
  21. Katsnelson, B.A.; Morosova, K.I.; Velichkovski, B.T.; Aronova, G.V.; Genkin, A.M.; Rotenberg, Y.S.; Belobragina, G.V.; Elnichnykh, L.N.; Privalova, L.I. Anti-silikotische Wirkung von Glutamat. Arbeitsmed. Sozialmed. Praventivmed. 1984, 19, 153–156. [Google Scholar]
  22. Chaudhary, R.G.; Bhusari, G.S.; Tiple, A.D.; Rai, A.R.; Somkuvar, S.R.; Potbhare, A.K.; Lambat, T.L.; Ingle, P.P.; Abdala, A.A. Metal/metal oxide nanoparticles: Toxicity, applications, and future prospects. Curr. Pharm. Des. 2019, 25, 4013–4029. [Google Scholar] [CrossRef] [PubMed]
  23. Karlsson, H.L.; Cronholm, P.; Gustafsson, J.; Möller, L. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21, 1726–1732. [Google Scholar] [CrossRef] [PubMed]
  24. Pohanka, M. Copper and copper nanoparticles toxicity and their impact on basic functions in the body. Bratisl. Lek. Listy 2019, 120, 397–409. [Google Scholar] [CrossRef] [PubMed]
  25. Kwon, J.T.; Kim, Y.; Choi, S.; Yoon, B.L.; Kim, H.S.; Shim, I.; Sul, D. Pulmonary toxicity and proteomic analysis in bronchoalveolar lavage fluids and lungs of rats exposed to copper oxide nanoparticles. Int. J. Mol. Sci. 2022, 23, 13265. [Google Scholar] [CrossRef] [PubMed]
  26. Cuillel, M.; Chevallet, M.; Charbonnier, P.; Fauquant, C.; Pignot-Paintrand, I.; Arnaud, J.; Cassio, D.; Michaud-Soret, I.; Mintz, E. Interference of CuO nanoparticles with metal homeostasis in hepatocytes under sub-toxic conditions. Nanoscale 2014, 6, 1707–1715. [Google Scholar] [CrossRef]
  27. The National Institute for Occupational Safety and Health (NIOSH). Immediately Dangerous to Life or Health (IDLH) Values. Available online: https://www.cdc.gov/niosh/idlh/intridl4.html (accessed on 29 December 2022).
  28. Jeong, M.J.; Jeon, S.; Yu, H.S.; Cho, W.S.; Lee, S.; Kang, D.; Kim, Y.; Kim, Y.J.; Kim, S.Y. Exposure to nickel oxide nanoparticles induces acute and chronic inflammatory responses in rat lungs and perturbs the lung microbiome. Int. J. Environ. Res. Public Health 2022, 19, 522. [Google Scholar] [CrossRef]
  29. Bai, K.J.; Chuang, K.J.; Chen, J.K.; Hua, H.E.; Shen, Y.L.; Liao, W.N.; Lee, C.H.; Chen, K.Y.; Lee, K.Y.; Hsiao, T.C.; et al. Investigation into the pulmonary inflammopathology of exposure to nickel oxide nanoparticles in mice. Nanomedicine 2018, 14, 2329–2339. [Google Scholar] [CrossRef]
  30. Mo, Y.; Zhang, Y.; Wan, R.; Jiang, M.; Xu, Y.; Zhang, Q. miR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis. Nanotoxicology 2020, 14, 1175–1197. [Google Scholar] [CrossRef]
  31. Sobańska, Z.; Roszak, J.; Kowalczyk, K.; Stępnik, M. Applications and biological activity of nanoparticles of manganese and manganese oxides in in vitro and in vivo models. Nanomaterials 2021, 11, 1084. [Google Scholar] [CrossRef]
  32. Guo, X.; Zhou, W.; Guan, Y.; Qin, J.; Zhang, B.; Zhang, M.; Tang, J. The protective effect of biomineralized BSA-Mn3O4 nanoparticles on HUVECs investigated by atomic force microscopy. Analyst 2022, 147, 2097–2105. [Google Scholar] [CrossRef] [PubMed]
  33. Zhou, Y.M.; Zhong, C.Y.; Kennedy, I.M.; Pinkerton, K.E. Pulmonary responses of acute exposure to ultrafine iron particles in healthy adult rats. Environ. Toxicol. 2003, 18, 227–235. [Google Scholar] [CrossRef]
  34. Teeguarden, J.G.; Mikheev, V.B.; Minard, K.R.; Forsythe, W.C.; Wang, W.; Sharma, G.; Karin, N.; Tilton, S.C.; Waters, K.M.; Asgharian, B.; et al. Comparative iron oxide nanoparticle cellular dosimetry and response in mice by the inhalation and liquid cell culture exposure routes. Part. Fibre Toxicol. 2014, 11, 46. [Google Scholar] [CrossRef] [PubMed]
  35. Guo, C.; Weber, R.J.M.; Buckley, A.; Mazzolini, J.; Robertson, S.; Delgado-Saborit, J.M.; Rappoport, J.Z.; Warren, J.; Hodgson, A.; Sanderson, P.; et al. Environmentally relevant iron oxide nanoparticles produce limited acute pulmonary effects in rats at realistic exposure levels. Int. J. Mol. Sci. 2021, 22, 556. [Google Scholar] [CrossRef] [PubMed]
  36. Fukui, H.; Endoh, S.; Shichiri, M.; Ishida, N.; Hagihara, Y.; Yoshida, Y.; Iwahashi, H.; Horie, M. The induction of lipid peroxidation during the acute oxidative stress response induced by intratracheal instillation of fine crystalline silica particles in rats. Toxicol. Ind. Health 2016, 32, 1430–1437. [Google Scholar] [CrossRef] [PubMed]
  37. Guichard, Y.; Maire, M.A.; Sébillaud, S.; Fontana, C.; Langlais, C.; Micillino, J.C.; Darne, C.; Roszak, J.; Stępnik, M.; Fessard, V.; et al. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 2: Intratracheal instillation and intravenous injection. Environ. Mol. Mutagen. 2015, 56, 228–244. [Google Scholar] [CrossRef]
  38. Guan, Y.; Liu, N.; Yu, Y.; Zhou, Q.; Chang, M.; Wang, Y.; Yao, S. Pathological comparison of rat pulmonary models induced by silica nanoparticles and indiumtin oxide nanoparticles. Int. J. Nanomed. 2022, 17, 4277–4292. [Google Scholar] [CrossRef]
  39. Katsnelson, B.A.; Privalova, L.I.; Sutunkova, M.P.; Minigalieva, I.A.; Gurvich, V.B.; Shur, V.Y.; Shishkina, E.V.; Makeyev, O.H.; Valamina, I.E.; Varaksin, A.N.; et al. Experimental research into metallic and metal oxide nanoparticle toxicity in vivo. In Bioactivity of Engineered Nanoparticles. Nanomedicine and Nanotoxicology; Yan, B., Zhou, H., Gardea-Torresdey, J., Eds.; Springer: Singapore, 2017; pp. 259–319. [Google Scholar] [CrossRef]
  40. Chen, Y.; Liu, W.; Leng, X.; Stoll, S. Toxicity of selenium nanoparticles on Poterioochromonas malhamensis algae in Waris-H culture medium and Lake Geneva water: Effect of nanoparticle coating, dissolution, and aggregation. Sci. Total Environ. 2022, 808, 152010. [Google Scholar] [CrossRef]
  41. Kodavanti, U.P. Respiratory toxicity biomarkers. In Biomarkers in Toxicology; Gupta, R., Ed.; Academic Press Incorporated: Orlando, FL, USA, 2014; Volume 1, pp. 217–239. [Google Scholar]
  42. Bahadar, H.; Maqbool, F.; Niaz, K.; Abdollahi, M. Toxicity of nanoparticles and an overview of current experimental models. Iran. Biomed. J. 2016, 20, 1–11. [Google Scholar] [CrossRef]
  43. Yang, W.; Wang, L.; Mettenbrink, E.M.; DeAngelis, P.L.; Wilhelm, S. Nanoparticle toxicology. Annu. Rev. Pharmacol. Toxicol. 2021, 61, 269–289. [Google Scholar] [CrossRef]
  44. Otsuki, M.; Yuu, H.; Maeda, M.; Saeki, S.; Yamasaki, T. Amylase in the lung. Cancer 1977, 39, 1656–1663. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, H.; Wu, Q. A case of amylase-producing small cell lung cancer. Clin. Biochem. 2016, 49, 613–616. [Google Scholar] [CrossRef] [PubMed]
  46. Berk, J.E.; Shimamura, J.; Fridhandler, L. Amylase changes in disorders of the lung. Gastroenterology 1978, 74, 1313–1317. [Google Scholar] [CrossRef]
  47. Fijačko, V.; Labor, M.; Fijačko, M.; Škrinjarić-Cincar, S.; Labor, S.; Dumbović Dubravčić, I.; Bačun, T.; Včev, A.; Popović-Grle, S.; Plavec, D. Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD. Wien. Klin. Wochenschr. 2018, 130, 247–258. [Google Scholar] [CrossRef] [PubMed]
  48. Suzuki, T.; Saitou, M.; Utano, Y.; Utano, K.; Niitsuma, K. Bronchoalveolar lavage amylase levels can be a biomarker of aspiration pneumonia. Eur. Respir. J. 2020, 56, 2354. [Google Scholar] [CrossRef]
  49. Suzuki, T.; Saitou, M.; Utano, Y.; Utano, K.; Niitsuma, K. Bronchoalveolar lavage (BAL) amylase and pepsin levels as potential biomarkers of aspiration pneumonia. Pulmonology 2022. [Google Scholar] [CrossRef]
  50. Faqi, A.S. (Ed.) A Comprehensive Guide to Toxicology in Nonclinical Drug Development, 2nd ed.; Academic Press: Cambridge, MA, USA, 2016. [Google Scholar]
  51. Erofeeva, E.A. Hormesis and paradoxical effects of wheat seedling (Triticum aestivum L.) parameters upon exposure to different pollutants in a wide range of doses. Dose Response 2013, 12, 121–135. [Google Scholar] [CrossRef]
  52. Panov, V.G.; Minigalieva, I.A.; Bushueva, T.V.; Artemenko, E.P.; Ryabova, I.V.; Sutunkova, M.P.; Gurvich, V.B.; Privalova, L.I.; Katsnelson, B.A. The various dose-dependent effect of selenium oxide and copper oxide nanoparticles in vitro and application of the hormesis paradigm. Hyg. Sanit. (Russ. J.) 2021, 100, 1475–1480. [Google Scholar] [CrossRef]
  53. Panov, V.; Bushueva, T.; Minigalieva, I.; Naumova, A.; Shur, V.; Shishkina, E.; Sutunkova, M.; Gurvich, V.; Privalova, L.; Katsnelson, B. New data on variously directed dose–response relationships and the combined action types for different outcomes of in Vitro nanoparticle cytotoxicity. Dose Response 2021, 19, 15593258211052420. [Google Scholar] [CrossRef]
  54. Tietz, N.W. Clinical Guide to Laboratory Tests, 4th ed.; W.B. Saunders Company: Philadelphia, PA, USA, 2006; 1952p. [Google Scholar]
Figure 1. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 1. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g001
Figure 2. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.25 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 2. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.25 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g002
Figure 3. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 3. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g003
Figure 4. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.25 mg per animal: (a) amylase; (b) GGT; (c) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 4. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of element oxide nanoparticles at a dose of 0.25 mg per animal: (a) amylase; (b) GGT; (c) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g004
Figure 5. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of copper oxide nanoparticles at doses of 0.2, 0.25 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 5. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of copper oxide nanoparticles at doses of 0.2, 0.25 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g005
Figure 6. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of copper oxide nanoparticles at doses of 0.2, 0.25, and 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 6. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of copper oxide nanoparticles at doses of 0.2, 0.25, and 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g006
Figure 7. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of lead oxide nanoparticles at doses of 0.2 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 7. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of lead oxide nanoparticles at doses of 0.2 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g007
Figure 8. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of lead oxide nanoparticles at doses of 0.2 and 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 8. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of lead oxide nanoparticles at doses of 0.2 and 0.5 mg per animal: (a) amylase; (b) ALT; (c) AST; (d) GGT; (e) LDH; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g008
Figure 9. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of nickel oxide nanoparticles at doses of 0.25 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Figure 9. Cellular parameters of the bronchoalveolar lavage fluid following intratracheal instillation of nickel oxide nanoparticles at doses of 0.25 and 0.5 mg per animal: (a) total cellularity; (b) number of neutrophilic leukocytes (NL); (c) number of alveolar macrophages (AM); (d) NL to AM ratio; the control is taken as 1, other values are given in relation to control. *—statistically different from the control groups (p < 0.05, based on Student’s t-test).
Ijms 24 08383 g009
Figure 10. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of nickel oxide nanoparticles at doses of 0.25 and 0.5 mg per animal: (a) amylase; (b) GGT; (c) LDH; the control is taken as 1, other values are given in relation to control.
Figure 10. Biochemical parameters of the supernatant of bronchoalveolar lavage fluid following intratracheal instillation of nickel oxide nanoparticles at doses of 0.25 and 0.5 mg per animal: (a) amylase; (b) GGT; (c) LDH; the control is taken as 1, other values are given in relation to control.
Ijms 24 08383 g010
Figure 11. Nanoparticles of various chemical natures synthesized for animal experiments by laser ablation. Images of nanoparticles obtained by scanning electron microscopy at ×30,000.
Figure 11. Nanoparticles of various chemical natures synthesized for animal experiments by laser ablation. Images of nanoparticles obtained by scanning electron microscopy at ×30,000.
Ijms 24 08383 g011
Table 1. Size and doses of nanoparticles.
Table 1. Size and doses of nanoparticles.
Nanoparticles Size, nmDoses, mg/mL
CuO24.5 ± 4.80.2
21.0 ± 4.00.25
21.0 ± 4.00.5
PbO47.0 ± 16.00.2
23.0 ± 5.00.5
CdO65.0 ± 16.00.5
Fe2O318.0 ± 4.00.5
NiO16.7 ± 8.20.25
16.7 ± 8.20.5
SiO243.0 ± 11.00.5
Mn3O418.4 ± 5.40.25
SeO51.0 ± 14.00.25
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sutunkova, M.P.; Klinova, S.V.; Ryabova, Y.V.; Tazhigulova, A.V.; Minigalieva, I.A.; Shabardina, L.V.; Solovyeva, S.N.; Bushueva, T.V.; Privalova, L.I. Comparative Evaluation of the Cytotoxic Effects of Metal Oxide and Metalloid Oxide Nanoparticles: An Experimental Study. Int. J. Mol. Sci. 2023, 24, 8383. https://doi.org/10.3390/ijms24098383

AMA Style

Sutunkova MP, Klinova SV, Ryabova YV, Tazhigulova AV, Minigalieva IA, Shabardina LV, Solovyeva SN, Bushueva TV, Privalova LI. Comparative Evaluation of the Cytotoxic Effects of Metal Oxide and Metalloid Oxide Nanoparticles: An Experimental Study. International Journal of Molecular Sciences. 2023; 24(9):8383. https://doi.org/10.3390/ijms24098383

Chicago/Turabian Style

Sutunkova, Marina P., Svetlana V. Klinova, Yuliya V. Ryabova, Anastasiya V. Tazhigulova, Ilzira A. Minigalieva, Lada V. Shabardina, Svetlana N. Solovyeva, Tatiana V. Bushueva, and Larisa I. Privalova. 2023. "Comparative Evaluation of the Cytotoxic Effects of Metal Oxide and Metalloid Oxide Nanoparticles: An Experimental Study" International Journal of Molecular Sciences 24, no. 9: 8383. https://doi.org/10.3390/ijms24098383

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop